These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 717388)

  • 21. Quantitative effect of combined chemotherapy and fractionated radiotherapy on the incidence of radiation-induced lung damage: a prospective clinical study.
    Mah K; Keane TJ; Van Dyk J; Braban LE; Poon PY; Hao Y
    Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):563-74. PubMed ID: 7509329
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
    Paoli D; Rizzo F; Fiore G; Pallotti F; Pulsoni A; Annechini G; Lombardo F; Lenzi A; Gandini L
    Hum Reprod; 2016 Feb; 31(2):263-72. PubMed ID: 26705149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytostatic drugs are without significant effect on digitoxin plasma level and renal excretion.
    Kuhlmann J; Wilke J; Rietbrock N
    Clin Pharmacol Ther; 1982 Nov; 32(5):646-51. PubMed ID: 6897028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitation by gas chromatography-chemical ionization mass spectrometry of cyclophosphamide, phosphoramide mustard, and nornitrogen mustard in the plasma and urine of patients receiving cyclophosphamide therapy.
    Jardine I; Fenselau C; Appler M; Kan MN; Brundrett RB; Colvin M
    Cancer Res; 1978 Feb; 38(2):408-15. PubMed ID: 620410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of dietary carrot on cytostatic drug activity of cyclophosphamide and its main directly acting metabolite: induction of sister-chromatid exchanges in normal human lymphocytes, Chinese hamster ovary cells, and their DNA repair-deficient cell lines.
    Darroudi F; Targa H; Natarajan AT
    Mutat Res; 1988 Apr; 198(2):327-35. PubMed ID: 3352640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination chemotherapy of Hodgkin's disease in children.
    Kolygin BA
    Cancer; 1976 Oct; 38(4):1494-7. PubMed ID: 991072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transport of nitrogen mustard on the transport-carrier for choline in L5178Y lymphoblasts.
    Goldenberg GJ; Vanstone CL; Bihler I
    Science; 1971 Jun; 172(3988):1148-9. PubMed ID: 5574521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the antifertility effects of alkylating agents and vinca alkaloids in male rats.
    Cooke RA; Nikles A; Roeser HP
    Br J Pharmacol; 1978 Aug; 63(4):677-81. PubMed ID: 687878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical studies and clinical correlation of the effect of alkylating dose.
    Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
    Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study.
    Bakemeier RF; Anderson JR; Costello W; Rosner G; Horton J; Glick JH; Hines JD; Berard CW; DeVita VT
    Ann Intern Med; 1984 Oct; 101(4):447-56. PubMed ID: 6089632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. European experience with ifosfamide in lymphomas.
    von Kalle AK; Schaadt M; Diehl V
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):73-7. PubMed ID: 2468184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-linking of DNA in L1210 cells and nuclei treated with cyclophosphamide and phosphoramide mustard.
    Surya YA; Rosenfeld JM; Hillcoat BL
    Cancer Treat Rep; 1978 Jan; 62(1):23-9. PubMed ID: 564237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
    Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R
    Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
    Nath K; Nelson DS; Putt ME; Leeper DB; Garman B; Nathanson KL; Glickson JD
    PLoS One; 2016; 11(6):e0157125. PubMed ID: 27285585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors for Stage IV Hodgkin's disease treated with MOPP, with or without bleomycin.
    Pillai GN; Hagemeister FB; Velasquez WS; Sullivan JA; Johnston DA; Butler JJ; Shullenberger CC
    Cancer; 1985 Feb; 55(4):691-7. PubMed ID: 2578302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of chromosome breaks and sister chromatid exchanges in patients with Hodgkin's disease by two combination chemotherapy regimens of different leukemogenic potential.
    Sen P; Bailey NM; Hagemeister FB; Liang JC
    Cancer Res; 1990 Feb; 50(3):558-62. PubMed ID: 1688733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of single and combined chemotherapeutic agents on hemopoietic stem cells in mice.
    Jenkins VK; Costanzi JJ; Ellis HN
    Am J Hematol; 1976; 1(1):79-88. PubMed ID: 984038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription-terminating lesions induced by bifunctional alkylating agents in vitro.
    Pieper RO; Futscher BW; Erickson LC
    Carcinogenesis; 1989 Jul; 10(7):1307-14. PubMed ID: 2736721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease.
    van Rijswijk RE; Haanen C; Dekker AW; de Meijer AJ; Verbeek J
    J Clin Oncol; 1989 Dec; 7(12):1776-82. PubMed ID: 2585019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.